Delek US Holdings (DK) Q3 2026 Earnings Call Transcript

Delek US Holdings (DK) reported Q3 2026 net income of $1.13B ($18.22/ share) and EBITDA of $1.64B. The company raised its EOP target to $250M annually and expects $425M in SRE proceeds. DKL increased 2026 EBITDA guidance to $530M-$560M. Delek plans $100M in share buybacks and raised its dividend to $0.30/share.

Original reporting
Published Nov 6, 2026, 9:03 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 6, 2026, 9:16 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Delek US Holdings (DK) Q3 2026 Earnings Call Transcript — source image
Decision brief

The 30-second read

$DKBullishMed
01

Why it matters

The guidance raise and dividend hike are likely to boost the stock, while the buyback adds further support.

02

Market read

Earnings guidance and dividend news provide fresh, material information for traders.

03

What to watch

Potential regulatory changes to the Renewable Fuel Standard could affect future earnings.

Relevance 8/10Novelty 8/10Timing: after‑hours earnings release

Background

Delek US Holdings discussed Q3 performance, raised 2026 EBITDA guidance, and announced a dividend increase and buyback plans.

Company-level read

Ticker impact

$DKBullishHigh confidence
Context

Delek US raised its 2026 EBITDA guidance to $530‑$560 million and increased its quarterly dividend to $0.30 per share.

Expected impact

upside pressure as investors price in higher EBITDA and dividend increase

Evidence & confidence

The guidance raise and dividend hike are fresh, material numbers that directly affect valuation.

Market effects

Higher midstream EBITDA may lift peer refiners and midstream operators.

Positive for U.S. energy sector amid elevated freight rates.

Limited to U.S. energy equities; no broader macro effect.

Counterpoint

If freight rates normalize, the guidance uplift could be overstated.

Key entities

  • Delek US Holdings

    U.S. downstream energy company (ticker DK).

Related articles

$DKMed

Why is Delek US stock rallying today?

Delek US Holdings (DK) stock rose 5.1% after an analyst upgrade to Buy with a $88 price target, citing strong Q3 2026 earnings. The company reported adjusted EPS of $13.55 and revenue of $4.39B, exceeding estimates. The board increased the dividend by 18% and authorized $100M in share repurchases. Institutional investors, holding 97% of shares, have been active in recent filings.

$DKHighAI 8/10

Freedom Broker upgrades Delek US stock rating on strong earnings

Freedom Broker upgraded Delek US (NYSE:DK) to Buy, raising its price target to $88. The company reported strong Q3 earnings, with adjusted net income nearly doubling to $843.0 million. DK cut net debt by $506.4 million and increased its dividend by 18%. The stock trades at a P/E ratio of 3.31 with a free cash flow yield of 32%. Raymond James also raised its price target to $95, citing strong macroeconomic conditions and operational improvements.

$DKMedAI 8/10

Delek US Holdings Inc (DK) (Q3 2026) Earnings Call Highlights: Record Net Income, Raised

Delek US Holdings Inc (DK) reported Q3 2026 net income with $809M working capital outflow, $4.6M asphalt segment loss, and no DKTS guidance due to market volatility. CEO Soreq highlighted SRE benefits, cash flow plans, and EOP improvements. Analysts noted RIN uncertainty and El Dorado refinery's low capture rate. The company expects $700M-$800M mid-cycle free cash flow and maintains a disciplined capital allocation strategy.

$DKMed

Mizuho reiterates Delek US stock rating at Neutral on Q3 beat

Mizuho reiterated a Neutral rating and $83.00 price target for Delek US (DK). The company's Q3 2026 EBITDA and EPS exceeded expectations, driven by strong refining margins. Delek raised its free cash flow target to $250M and narrowed its 2026 EBITDA guidance for DK Logistics. Shares are down 15% in the past week but up 114% year-to-date. Analysts expect net income growth and see the stock as undervalued.